InflaRx (IFRX) Assets Average (2017 - 2026)
InflaRx's (IFRX) quarterly Assets Average came in at $60.8 million in Q1 2026, down 29.66% year-on-year from $86.4 million in Q1 2025, and down 13.48% quarter-over-quarter from $70.2 million in Q4 2025.
InflaRx (IFRX) Assets Average (2017 - 2026) Analysis & Trends
InflaRx has disclosed Assets Average across 10 years of filings, most recently posting $60.8 million for Q1 2026.
- Assets Average for Q1 2026 came in at $60.8 million, down 29.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.8 million (down 29.66% YoY), and the FY2025 annual result was $72.8 million, down 30.9% from the prior year.
- Assets Average came in at $60.8 million for Q1 2026 at InflaRx, down from $70.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $142.9 million in Q3 2023 to a low of $60.8 million in Q1 2026.
- The 5-year median for Assets Average is $108.3 million (2022), against an average of $104.5 million.
- Across the five-year window, Assets Average gained 24.84% in 2023 and sank 37.57% in 2024, its largest moves.
- InflaRx's Assets Average stood at $108.3 million in 2022, then climbed by 24.84% to $135.1 million in 2023, then slumped by 37.57% to $84.4 million in 2024, then dropped by 16.77% to $70.2 million in 2025, then declined by 13.48% to $60.8 million in 2026.
- The last three Assets Average figures came in at $60.8 million (Q1 2026), $70.2 million (Q4 2025), and $79.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 660.38 Mn |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | 60.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.76 Mn |
| Dec 31, 2025 | 70.22 Mn |
| Sep 30, 2025 | 79.65 Mn |
| Jun 30, 2025 | 87.32 Mn |
| Mar 31, 2025 | 86.37 Mn |
| Dec 31, 2024 | 84.37 Mn |
| Sep 30, 2024 | 93.85 Mn |
| Jun 30, 2024 | 108.27 Mn |
| Mar 31, 2024 | 122.84 Mn |
| Dec 31, 2023 | 135.15 Mn |
| Sep 30, 2023 | 142.87 Mn |
| Jun 30, 2023 | 118.71 Mn |
| Mar 31, 2023 | 98.56 Mn |
| Dec 31, 2022 | 108.26 Mn |
| Sep 30, 2022 | 117.18 Mn |
| Jun 30, 2022 | 125.74 Mn |
| Mar 31, 2022 | 136.16 Mn |
| Dec 31, 2021 | 147.86 Mn |
| Sep 30, 2021 | 157.59 Mn |
| Jun 30, 2021 | 170.11 Mn |